Celcuity Inc(CELC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CELC Celcuity Inc

休市中 12-05 16:00:00 EST

105.63

-0.24

-0.23%

盘后106.10

+0.47+0.44%

19:57 EST

最高107.78	最低105.00	成交量87.26万
今开106.12	昨收105.87	日振幅2.63%
总市值48.88亿	流通市值23.81亿	总股本4,627万
成交额9,272万	换手率3.87%	流通股本2,254万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CELC","market":"US","secType":"STK","nameCN":"Celcuity Inc","latestPrice":105.63,"timestamp":1764968400000,"preClose":105.87,"halted":0,"volume":872560,"hourTrading":{"tag":"盘后","latestPrice":106.1,"preClose":105.63,"latestTime":"19:57 EST","volume":42300,"amount":4468207.98,"timestamp":1764982629978},"delay":0,"floatShares":22539400,"shares":46271259,"eps":-3.672053,"marketStatus":"休市中","change":-0.24,"latestTime":"12-05 16:00:00 EST","open":106.12,"high":107.78,"low":105,"amount":92718194.18784,"amplitude":0.026259,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.672053,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1505880000000,"exchange":"NASDAQ","adjPreClose":105.87,"preHourTrading":{"tag":"盘前","latestPrice":106.03,"preClose":105.87,"latestTime":"09:25 EST","volume":260,"amount":27656.667999999998,"timestamp":1764944700033},"postHourTrading":{"tag":"盘后","latestPrice":106.1,"preClose":105.63,"latestTime":"19:57 EST","volume":42300,"amount":4468207.98,"timestamp":1764982629978},"volumeRatio":1.2563493471091425,"impliedVol":0.6967,"impliedVolPercentile":0.22},"requestUrl":"/m/hq/s/CELC","defaultTab":"news","newsList":[{"id":"1158543009","title":"Celcuity第三季度调整后每股收益为-0.78美元，IBES预估为-1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158543009","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158543009?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:32","pubTimestamp":1763573572,"startTime":"0","endTime":"0","summary":"11月12日 - Celcuity第三季度净亏损为4380万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"1102466399","title":"Celcuity宣布向美国FDA提交Gedatolisib的新药申请完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1102466399","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102466399?lang=zh_cn&edition=full","pubTime":"2025-11-18 05:06","pubTimestamp":1763413568,"startTime":"0","endTime":"0","summary":"Celcuity宣布已完成向美国FDA提交其新药申请，申请药物为Gedatolisib，适用于HR+/HER2-/PIK3CA野生型晚期乳腺癌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"1172385847","title":"盘前 | CELC、BYND暴涨，特斯拉、苹果涨超1%，矿产股普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1172385847","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172385847?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:08","pubTimestamp":1760962094,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段普涨。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"cfa4dccaf518a747a3375c8cfe4ca1f9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLA","BYND","AAPL","UAMY","CELC"],"gpt_icon":1},{"id":"1197584122","title":"Celcuity治疗前列腺癌最新数据显示出积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1197584122","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197584122?lang=zh_cn&edition=full","pubTime":"2025-10-20 19:05","pubTimestamp":1760958339,"startTime":"0","endTime":"0","summary":"10月20日，Celcuity盘前股价一度飙涨逾110%！公司在 2025 年 ESMO 年会上展示了 Gedatolisib 联合 Darolutamide 治疗转移性去势抵抗性前列腺癌 (mCRPC) 患者的 I 期研究的最新数据。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ec6003e0739268f20d9bbe4b456297b3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Celcuity治疗前列腺癌最新数据显示出积极结果","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC"],"gpt_icon":0},{"id":"1154680392","title":"Celcuity更新Viktoria-1三期试验中Pik3CA突变队列的状态及发布一期B临床试验的附加数据分析","url":"https://stock-news.laohu8.com/highlight/detail?id=1154680392","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154680392?lang=zh_cn&edition=full","pubTime":"2025-10-18 16:30","pubTimestamp":1760776218,"startTime":"0","endTime":"0","summary":"Celcuity更新Viktoria-1三期试验中Pik3CA突变队列的状态及发布一期B临床试验的附加数据分析","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"1135996065","title":"Celcuity Inc宣布与Innovatus Capital Partners和Oxford Finance达成5亿美元扩大规模优先担保定期贷款协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1135996065","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135996065?lang=zh_cn&edition=full","pubTime":"2025-09-10 04:01","pubTimestamp":1757448075,"startTime":"0","endTime":"0","summary":"Celcuity Inc宣布，公司已与Innovatus Capital Partners和Oxford Finance达成一项价值5亿美元的扩大规模优先担保定期贷款安排。\n此次贷款协议的达成，为Celcuity Inc提供了重要的资金支持，有助于公司进一步推进其业务发展计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"1100516979","title":"Celcuity Inc将在FDA实时肿瘤学审查项目下启动Gedatolisib在HR+/HER2-晚期乳腺癌PIK3CA野生型队列中的新药申请提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1100516979","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100516979?lang=zh_cn&edition=full","pubTime":"2025-08-28 04:07","pubTimestamp":1756325246,"startTime":"0","endTime":"0","summary":"Celcuity Inc将在FDA实时肿瘤学审查项目下启动Gedatolisib在HR+/HER2-晚期乳腺癌PIK3CA野生型队列中的新药申请提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"1132212992","title":"Celcuity 2025财年Q2业绩会总结及问答精华：gedatolisib临床试验数据推动新标准","url":"https://stock-news.laohu8.com/highlight/detail?id=1132212992","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132212992?lang=zh_cn&edition=full","pubTime":"2025-08-15 05:32","pubTimestamp":1755207153,"startTime":"0","endTime":"0","summary":"Celcuity管理层认为gedatolisib三联疗法和双联疗法有潜力成为HR阳性HER2阴性晚期乳腺癌患者的新标准治疗方案。公司强调gedatolisib的静脉注射形式在社区肿瘤实践和报销方面具有显著优势。与预期相比，Celcuity的研发支出增加，主要用于支持临床试验活动。公司在2025年Q2的净亏损为4530万美元，较2024年同期增加。Celcuity在2025年Q2取得了显著的临床和财务进展，尤其是在gedatolisib的临床试验数据方面。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC"],"gpt_icon":1},{"id":"1165227836","title":"Form 4 | Celcuity董事 David Dalvey 减持126345股","url":"https://stock-news.laohu8.com/highlight/detail?id=1165227836","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165227836?lang=zh_cn&edition=full","pubTime":"2025-07-31 04:20","pubTimestamp":1753906817,"startTime":"0","endTime":"0","summary":"Celcuity董事 David Dalvey 于2025年7月28日进行过多次减持，共出售126345股普通股票。这些出售业务通过一项规则10b5-1交易计划进行，减持价格范围在42.94至46.06美元之间。这表明公司股票可能被高估，投资者需密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Form 4 | Celcuity董事 David Dalvey 减持126345股","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC"],"gpt_icon":0},{"id":"1153556752","title":"异动解读 | Celcuity股价盘前大跌5.76%，或因前日大涨后获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1153556752","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153556752?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:04","pubTimestamp":1753776285,"startTime":"0","endTime":"0","summary":"生物技术公司Celcuity Inc今日盘前股价大跌5.76%，引发市场关注。这一跌势与前一交易日的大幅上涨形成鲜明对比，可能反映了投资者的获利回吐行为。根据交易数据，Celcuity在7月28日经历了惊人的167.18%的涨幅，股价报收于36.79美元。该股票在过去5个交易日内累计上涨171.71%，年初至今涨幅更是高达181.05%。值得注意的是，尽管出现盘前跌势，多家券商仍然看好Celcuity的前景。投资者应密切关注Celcuity的后续走势，权衡短期波动与长期发展前景。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CELC"],"gpt_icon":1},{"id":"2554772038","title":"美股异动 | 治疗乳腺癌药物3期实验显示出积极结果 Celcuity(CELC.US)飙升超210%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554772038","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554772038?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:42","pubTimestamp":1753710178,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"1153520747","title":"盘前 | celcuity涨逾200%，AEye延续强势，文远知行涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1153520747","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153520747?lang=zh_cn&edition=full","pubTime":"2025-07-28 20:32","pubTimestamp":1753705926,"startTime":"0","endTime":"0","summary":"美股三大指数期货在盘前时段小幅走高。","market":"us","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a5d8fe3cce125debd1d2c957e6fddcbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC","LIDR","WRD"],"gpt_icon":1},{"id":"1167424936","title":"异动解读 | Celcuity股价盘前暴涨241.87%，乳腺癌新药试验数据亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1167424936","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167424936?lang=zh_cn&edition=full","pubTime":"2025-07-28 20:22","pubTimestamp":1753705347,"startTime":"0","endTime":"0","summary":"周一盘前，生物技术公司Celcuity Inc股价大幅上涨241.87%，引发市场广泛关注。这一显著涨幅主要源于该公司最新公布的乳腺癌药物临床试验结果令人振奋。据报道，Celcuity的实验性联合疗法在晚期临床试验中表现出色。值得注意的是，Celcuity表示，这种新疗法的耐受性比之前的早期研究更好，高血糖和口腔炎症等副作用的发生率更低。随着公司计划在今年晚些时候公布完整的试验结果，市场将继续密切关注Celcuity的后续进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a5d8fe3cce125debd1d2c957e6fddcbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["CELC"],"gpt_icon":1},{"id":"2554713177","title":"Celcuity盘前大涨206%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554713177","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554713177?lang=zh_cn&edition=full","pubTime":"2025-07-28 20:18","pubTimestamp":1753705129,"startTime":"0","endTime":"0","summary":"格隆汇7月28日｜生物技术公司Celcuity股票涨势延续，盘前最高涨幅达206.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072820192097233033&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"a5d8fe3cce125debd1d2c957e6fddcbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072820192097233033&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"1174811241","title":"Celcuity暴涨220%，公司的实验性疗法可延缓乳癌扩散","url":"https://stock-news.laohu8.com/highlight/detail?id=1174811241","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174811241?lang=zh_cn&edition=full","pubTime":"2025-07-28 20:03","pubTimestamp":1753704181,"startTime":"0","endTime":"0","summary":"在晚期试验中帮助延缓了乳癌扩散。","market":"us","thumbnail":"https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/bc7ad619aa7e42a7db4703997b65806b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a5d8fe3cce125debd1d2c957e6fddcbc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Celcuity公司的实验性疗法可延缓乳癌扩散","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CELC"],"gpt_icon":0},{"id":"2508147715","title":"Celcuity Inc.盘中异动 大幅拉升5.31%报12.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508147715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508147715?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:34","pubTimestamp":1738596849,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时34分，Celcuity Inc.股票出现波动，股价快速拉升5.31%。截至发稿，该股报12.59美元/股，成交量3.2582万股，换手率0.09%，振幅8.79%。Celcuity Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为543.95%、418.49%、343.83%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为158.16%、75.23%、53.59%。Celcuity Inc.公司简介：Celcuity Inc 是一家致力于开发肿瘤学方向的临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323340998797904&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020323340998797904&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"2508120960","title":"Celcuity Inc.盘中异动 大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508120960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508120960?lang=zh_cn&edition=full","pubTime":"2025-02-01 00:50","pubTimestamp":1738342225,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日00时50分，Celcuity Inc.股票出现异动，股价急速拉升5.03%。Celcuity Inc.股票所在的生物技术行业中，整体涨幅为1.47%。其相关个股中，Cyclerion Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃，换手率分别为2126.43%、1938.99%、182.85%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cyclerion Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为80.00%、56.30%、52.24%。Celcuity Inc.公司简介：Celcuity Inc 是一家致力于开发肿瘤学方向的临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201005026a2355b48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201005026a2355b48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2506306258","title":"Celcuity Inc.盘中异动 早盘大幅拉升5.28%报12.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506306258?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:50","pubTimestamp":1737989438,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时50分，Celcuity Inc.股票出现波动，股价大幅上涨5.28%。截至发稿，该股报12.02美元/股，成交量1.0472万股，换手率0.03%，振幅4.99%。Celcuity Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Celcuity Inc.公司简介：Celcuity Inc 是一家致力于开发肿瘤学方向的临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225038abba6408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127225038abba6408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELC","BK4139"],"gpt_icon":0},{"id":"2503628458","title":"Celcuity Inc.盘中异动 早盘大幅拉升5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503628458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503628458?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951529,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Celcuity Inc.股票出现波动，股价快速拉升5.41%。Celcuity Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为184.95%、52.43%、35.39%，振幅较大的相关个股有Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.、Viracta Therapeutics, Inc.，振幅分别为12.00%、10.72%、9.48%。Celcuity Inc.公司简介：Celcuity Inc 是一家致力于开发肿瘤学方向的临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223209a222fe03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223209a222fe03&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CELC"],"gpt_icon":0},{"id":"2503831525","title":"Celcuity Inc.盘中异动 早盘急速跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503831525","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503831525?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:35","pubTimestamp":1736778954,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时35分，Celcuity Inc.股票出现异动，股价急速下跌5.54%。Celcuity Inc.股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3379.01%、2095.08%、392.79%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、60.36%。Celcuity Inc.公司简介：Celcuity Inc 是一家致力于开发肿瘤学方向的临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223554a220409d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223554a220409d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CELC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.celcuity.com","stockEarnings":[{"period":"1week","weight":0.0444},{"period":"1month","weight":0.4161},{"period":"3month","weight":0.8969},{"period":"6month","weight":7.0943},{"period":"1year","weight":7.37},{"period":"ytd","weight":7.0695}],"compareEarnings":[{"period":"1week","weight":0.0034},{"period":"1month","weight":0.012},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1445},{"period":"1year","weight":0.1303},{"period":"ytd","weight":0.17}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Celcuity Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发治疗多种实体瘤适应症的靶向疗法。该公司的主要治疗候选药物是gedatolisib，这是一种强效、耐受性良好的小分子可逆抑制剂，静脉给药，可选择性靶向磷脂酰肌醇-3-激酶（PI3K）的所有I类异构体和雷帕霉素（mTOR）的两个机制靶点mTORC1和mTORC2。Gedatolisib的作用机制和药代动力学特性与目前已获批准和在研的单独或一起靶向PI3K或mTOR的疗法有很大区别。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.009489},{"month":2,"riseRate":0.5,"avgChangeRate":-0.033676},{"month":3,"riseRate":0.375,"avgChangeRate":-0.004434},{"month":4,"riseRate":0.625,"avgChangeRate":0.07262},{"month":5,"riseRate":0.5,"avgChangeRate":0.066491},{"month":6,"riseRate":0.75,"avgChangeRate":0.098934},{"month":7,"riseRate":0.25,"avgChangeRate":0.179591},{"month":8,"riseRate":0.625,"avgChangeRate":0.016512},{"month":9,"riseRate":0.375,"avgChangeRate":-0.012139},{"month":10,"riseRate":0.555556,"avgChangeRate":0.125622},{"month":11,"riseRate":0.444444,"avgChangeRate":0.071442},{"month":12,"riseRate":0.444444,"avgChangeRate":0.034526}],"exchange":"NASDAQ","name":"Celcuity Inc","nameEN":"Celcuity Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Celcuity Inc(CELC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Celcuity Inc(CELC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Celcuity Inc,CELC,Celcuity Inc股票,Celcuity Inc股票老虎,Celcuity Inc股票老虎国际,Celcuity Inc行情,Celcuity Inc股票行情,Celcuity Inc股价,Celcuity Inc股市,Celcuity Inc股票价格,Celcuity Inc股票交易,Celcuity Inc股票购买,Celcuity Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Celcuity Inc(CELC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Celcuity Inc(CELC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}